Table 2.
Men | Women | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Study Factor | Method | Quintile | IRR (95% CI) | p-value (quintiles) |
p-value (cont.)a |
ΔBIC | Evidence | IRR (95% CI) | p-value (quintiles) |
p-value (cont.)a |
ΔBIC | Evidence |
Smoking | No-lag | 1 | 1 | <0.001 | 2 | Positive | 1 | <0.001 | −5.4 | No Improvement | ||
2 | 0.92 (0.82-1.04) | 0.21 | 1.13 (0.99-1.28) | 0.07 | ||||||||
3 | 0.98 (0.87-1.10) | 0.71 | 1.20 (1.06-1.37)** | 0.005 | ||||||||
4 | 1.11 (0.95-1.29) | 0.19 | 1.28 (1.11-1.48)*** | <0.001 | ||||||||
5 | 1.26 (1.04-1.53)* | 0.02 | 1.37 (1.13-1.66)** | 0.002 | ||||||||
Lagged | 1 | 1 | <0.001 | −0.9 | No Improvement | 1 | <0.001 | 7.7 | Strong | |||
2 | 1.12 (1.02-1.24)* | 0.02 | 1.15 (1.07-1.24)*** | <0.001 | ||||||||
3 | 1.13 (1.01-1.27)* | 0.03 | 1.19 (1.07-1.32)** | 0.002 | ||||||||
4 | 1.21 (1.06-1.37)** | 0.004 | 1.26 (1.10-1.43)*** | <0.001 | ||||||||
5 | 1.33 (1.14-1.55)*** | <0.001 | 1.39 (1.18-1.62)*** | <0.001 | ||||||||
AMC no-lag | 1.14 (1.05-1.23)*** | <0.001 | 6.1 | Strong | 1.12 (1.03-1.21)** | 0.005 | 3.3 | Positive | ||||
AMC lagged | 1.17 (1.10-1.24)*** | <0.001 | 21.4 | Very Strong | 1.15 (1.09-1.21)*** | <0.001 | 21 | Very Strong | ||||
AMC cumulative | 1.20 (1.13-1.29)*** | <0.001 | 24.9 | Very Strong | 1.19 (1.12-1.27)*** | <0.001 | 27.8 | Very Strong | ||||
Alcohol | No-lag | 1 | 1 | 0.5 | −15.5 | No Improvement | 1 | 0.81 | −4.9 | No Improvement | ||
2 | 0.98 (0.88-1.09) | 0.72 | 0.87 (0.78-0.96)** | 0.009 | ||||||||
3 | 1.02 (0.91-1.15) | 0.69 | 0.87 (0.77-0.97)* | 0.01 | ||||||||
4 | 0.99 (0.89-1.11) | 0.92 | 0.98 (0.89-1.09) | 0.76 | ||||||||
5 | 1.03 (0.92-1.16) | 0.57 | 0.92 (0.83-1.03) | 0.14 | ||||||||
Alcohol | Lagged | 1 | 1 | <0.001 | 8.1 | Strong | 1 | <0.001 | 16.3 | Very Strong | ||
2 | 1.10 (0.97-1.24) | 0.13 | 1.04 (0.94-1.15) | 0.45 | ||||||||
3 | 1.17 (1.05-1.31)** | 0.005 | 1.02 (0.91-1.13) | 0.77 | ||||||||
4 | 1.27 (1.13-1.43)*** | <0.001 | 1.15 (1.05-1.26)** | 0.003 | ||||||||
5 | 1.28 (1.13-1.46)*** | <0.001 | 1.23 (1.11-1.37)*** | <0.001 | ||||||||
AMC no-lag | 1.03 (1-1.06)* | 0.03 | 0.3 | Weak | 1 (0.97-1.04) | 0.81 | −4.2 | No Improvement | ||||
AMC lagged | 1.08 (1.04-1.12)*** | <0.001 | 11.3 | Very Strong | 1.08 (1.04-1.11)*** | <0.001 | 15.6 | Very Strong | ||||
AMC cumulative | 1.06 (1.03-1.09)*** | <0.001 | 14.5 | Very Strong | 1.07 (1.04-1.11)*** | <0.001 | 17.7 | Very Strong | ||||
Calcium | No-lag | 1 | 1 | 0.44 | 6 | Positive | 1 | 0.008 | 16.2 | Very Strong | ||
2 | 0.91 (0.81-1.01) | 0.08 | 0.87 (0.78-0.98)* | 0.02 | ||||||||
3 | 0.85 (0.74-0.97)* | 0.01 | 0.81 (0.71-0.92)** | 0.001 | ||||||||
4 | 0.88 (0.76-1.03) | 0.1 | 0.74 (0.62-0.87)*** | <0.001 | ||||||||
5 | 0.96 (0.77-1.19) | 0.69 | 0.80 (0.63-1.01) | 0.06 | ||||||||
Lagged | 1 | 1 | 0.29 | −3.7 | No Improvement | 1 | 0.04 | 13.5 | Very Strong | |||
2 | 0.86 (0.77-0.96)** | 0.006 | 0.92 (0.83-1.02) | 0.12 | ||||||||
3 | 0.84 (0.74-0.97)* | 0.02 | 0.80 (0.70-0.91)*** | <0.001 | ||||||||
4 | 0.85 (0.73-0.99)* | 0.04 | 0.81 (0.69-0.95)** | 0.01 | ||||||||
5 | 0.85 (0.70-1.04) | 0.12 | 0.90 (0.73-1.10) | 0.31 | ||||||||
AMC no-lag | 1 (0.96-1.04) | 0.86 | −4.2 | No Improvement | 0.90 (0.84-0.97)** | 0.008 | 2.2 | Positive | ||||
AMC lagged | 0.98 (0.95-1.01) | 0.12 | −1.4 | No Improvement | 1.03 (0.95-1.11) | 0.46 | −3.3 | No Improvement | ||||
AMC cumulative | 0.98 (0.94-1.02) | 0.33 | −3.1 | No Improvement | 0.98 (0.90-1.06) | 0.6 | −3.8 | No Improvement |
P<0.05
P<0.01
P<0.001; IRR=Incidence rate ratio; BIC=Bayesian information criterion; AMC=Age-mean centering.
IRRs were adjusted for age, period, and race.
For the no-lag and lagged models, we generated p-value (cont.) by treating the median of the quintiles as a continuous variable in regression.